CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			47,594,930
Beginning balance	$ (7,419)	$ (126,116)	$ (4,825)	$ (130,328)
Common stock withheld for taxes		(12)		(16)
Stock-based compensation	45	161	109	357
Net income (loss)	$ (176)	108,639	$ (2,834)	112,659
Ending balance (in shares)	47,610,653		47,610,653
Ending balance	$ (7,550)	$ (17,328)	$ (7,550)	$ (17,328)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	47,602,790	47,560,952	47,594,930	47,556,267
Beginning balance	$ 482	$ 475	$ 482	$ 475
Issuance of common stock for restricted stock units (in shares)	7,863	4,999	15,723	12,498
Common stock withheld for taxes, (in shares)		(2,061)		(4,875)
Issuance of common stock upon exercise of stock options (in shares)		717		717
Ending balance (in shares)	47,610,653	47,564,607	47,610,653	47,564,607
Ending balance	$ 482	$ 475	$ 482	$ 475
Common To Be Issued
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	2,701	2,701	2,701	2,701
Beginning balance	$ 0	$ 0	$ 0	$ 0
Ending balance (in shares)	2,701	2,701	2,701	2,701
Ending balance	$ 0	$ 0	$ 0	$ 0
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	349,262	348,752	349,198	348,560
Common stock withheld for taxes		(12)		(16)
Stock-based compensation	45	161	109	357
Ending balance	349,307	348,901	349,307	348,901
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(357,163)	(475,343)	(354,505)	(479,363)
Net income (loss)	(176)	108,639	(2,834)	112,659
Ending balance	$ (357,339)	$ (366,704)	$ (357,339)	$ (366,704)